| Cod Nacion | Nro Definitivo | Des Nomco | Des Prese | Cod Vtm | Cod Vmp | Cod Vmpp | Des Dosific | Cod Forfar | Cod Forfar Simplificada | Cod Envase | Contenido | Unid Contenido | Nro Conte | Cod Atc | Sw Psicotropo | Sw Estupefaciente | Sw Afecta Conduccion | Sw Triangulo Negro | Url Fictec | Url Prosp | Sw Receta | Sw Generico | Sw Sustituible | Sw Envase Clinico | Sw Uso Hospitalario | Sw Diagnostico Hospitalario | Sw Tld | Sw Especial Control Medico | Sw Huerfano | Sw Base A Plantas | Laboratorio Titular | Laboratorio Comercializador | Fecha Autorizacion | Sw Comercializado | Cod Sitreg | Cod Sitreg Presen | Fecha Situacion Registro | Fec Sitreg Presen | Sw Tiene Excipientes Decl Obligatoria | Nro Pactiv | Fec Comer | Lista Psicotropo | Cod Nacionales Inactivos | Lista Estupefaciente | Hash | Last Modified | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 676516 | 73057 | ROPIVACAINA KABI 10 MG/ML SOLUCION INYECTABLE EFG | ROPIVACAINA KABI 10 MG/ML SOLUCION INYECTABLE EFG , 5 ampollas de 10 ml | 10 mg/ml inyectable 10 ml | 1 | 5 | 1 | 5 ampollas de 10 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/73057/73057_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/73057/73057_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 14285 | FRESENIUS KABI ESPAÑA, S.A.U. | 2014-11-11 | 1 | 1 | 1 | 2014-11-11 | 2014-11-13 | 1 | 2015-05-26 | View Edit Delete | ||||||||||||
| 677339 | 73280 | HIDROCLORURO DE EFEDRINA KABI 30 mg/ml SOLUCION INYECTABLE | HIDROCLORURO DE EFEDRINA KABI 30 mg/ml SOLUCION INYECTABLE, 10 ampollas de 1 ml | 30 mg/ml inyectable 1 ml | 1 | 10 | 1 | 10 ampollas de 1 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/73280/73280_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/73280/73280_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 14285 | FRESENIUS KABI ESPAÑA, S.A.U. | 2011-01-13 | 1 | 1 | 1 | 2011-01-13 | 2011-01-13 | 0 | 2020-04-02 | View Edit Delete | ||||||||||||
| 680397 | 61021 | VITALIPID INFANTIL | VITALIPID INFANTIL, 10 ampollas de 10 ml | 135,3 microgramos/ml + 1 microgramos/ml + 20 microgramos/ml + 640 microgramos/ml inyectable 10 ml | 1 | 10 | 1 | 10 ampollas de 10 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/61021/61021_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/61021/61021_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 14285 | FRESENIUS KABI ESPAÑA, S.A.U. | 1997-07-01 | 1 | 1 | 1 | 1997-07-01 | 1997-07-01 | 1 | 2011-02-09 | View Edit Delete | ||||||||||||
| 680405 | 61020 | VITALIPID ADULTOS | VITALIPID ADULTOS, 10 ampollas de 10 ml | 194,1 microgramos/ml + 0,5 microgramos/ml + 15 microgramos/ml + 910 microgramos/ml inyectable 10 ml | 1 | 10 | 1 | 10 ampollas de 10 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/61020/61020_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/61020/61020_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 14285 | FRESENIUS KABI ESPAÑA, S.A.U. | 1997-07-01 | 1 | 1 | 1 | 1997-07-01 | 1997-07-01 | 1 | 2011-02-09 | View Edit Delete | ||||||||||||
| 677362 | 73563 | SALBUAIR 2.5 mg SOLUCION PARA INHALACION POR NEBULIZADOR | SALBUAIR 2.5 mg SOLUCION PARA INHALACION POR NEBULIZADOR , 60 ampollas de 2,5 ml | 2,5 mg | 1 | 60 | 40 | 60 ampollas de 2,5 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/73563/73563_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/73563/73563_p.pdf | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 16620 | LABORATORIO ALDO UNION S.L. | 2011-02-22 | 1 | 1 | 1 | 2011-02-22 | 2011-02-22 | 1 | 2011-10-24 | View Edit Delete | ||||||||||||
| 677363 | 73562 | SALBUAIR 5 mg SOLUCION PARA INHALACION POR NEBULIZADOR | SALBUAIR 5 mg SOLUCION PARA INHALACION POR NEBULIZADOR, 60 ampollas de 2,5 ml | 5 mg | 1 | 60 | 40 | 60 ampollas de 2,5 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/73562/73562_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/73562/73562_p.pdf | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 16620 | LABORATORIO ALDO UNION S.L. | 2011-02-22 | 1 | 1 | 1 | 2011-02-22 | 2011-02-22 | 1 | 2011-10-24 | View Edit Delete | ||||||||||||
| 677602 | 73561 | COMBIPRASAL 0.5 mg/2.5 mg SOLUCION PARA INHALACION POR NEBULIZADOR | COMBIPRASAL 0.5 mg/2.5 mg SOLUCION PARA INHALACION POR NEBULIZADOR, 20 ampollas de 2,5 ml | 2,5 mg/0,5 mg | 1 | 20 | 40 | 20 ampollas de 2,5 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/73561/73561_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/73561/73561_p.pdf | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 16620 | LABORATORIO ALDO UNION S.L. | 2011-02-22 | 1 | 1 | 1 | 2011-02-22 | 2011-02-22 | 1 | 2011-10-24 | View Edit Delete | ||||||||||||
| 680678 | 61004 | PROGRAF 5 mg/ml CONCENTRADO PARA SOLUCION PARA PERFUSION | PROGRAF 5 mg/ml CONCENTRADO PARA SOLUCION PARA PERFUSION , 10 ampollas de 1 ml | 5 mg/ml inyectable 1 ml | 1 | 10 | 1 | 10 ampollas de 1 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/61004/61004_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/61004/61004_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 40569 | ASTELLAS PHARMA S.A. | 1996-07-01 | 1 | 1 | 1 | 1996-07-01 | 1996-07-01 | 1 | 2011-10-26 | View Edit Delete | ||||||||||||
| 675272 | 62628 | IMPLANON NXT 68 mg IMPLANTE | IMPLANON NXT 68 mg IMPLANTE , 1 implante con aplicador | 68 mg | 2 | 1 | 23 | 1 implante con aplicador | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/62628/62628_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/62628/62628_p.pdf | 1 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 35083 | ORGANON SALUD S.L. | 2000-12-14 | 1 | 1 | 1 | 2000-12-14 | 2000-12-14 | 0 | 2011-09-28 | View Edit Delete | ||||||||||||
| 676512 | 73055 | ROPIVACAINA KABI 2 MG/ML SOLUCION PARA PERFUSION EFG | ROPIVACAINA KABI 2 MG/ML SOLUCION PARA PERFUSION EFG , 5 bolsas de 100 ml | 2 mg/ml inyectable 10 ml | 3 | 5 | 65 | 5 bolsas de 100 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/73055/73055_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/73055/73055_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 14285 | FRESENIUS KABI ESPAÑA, S.A.U. | 2014-11-11 | 1 | 1 | 1 | 2014-11-11 | 2014-11-14 | 1 | 2015-05-26 | View Edit Delete | ||||||||||||
| 680268 | 74019 | NUMETA G16%E, EMULSION PARA PERFUSION | NUMETA G16%E, EMULSION PARA PERFUSION , 6 bolsas de 500 ml | N/A (más de 4 PA) | 3 | 6 | 65 | 6 bolsas de 500 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/74019/74019_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/74019/74019_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 7980 | BAXTER S.L. | 2011-05-09 | 1 | 1 | 1 | 2017-01-02 | 2017-01-02 | 1 | 2017-03-01 | View Edit Delete | ||||||||||||
| 680269 | 74020 | NUMETA G19%E, EMULSION PARA PERFUSION | NUMETA G19%E, EMULSION PARA PERFUSION , 6 bolsas de 1.000 ml | N/A (más de 4 PA) | 3 | 6 | 65 | 6 bolsas de 1.000 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/74020/74020_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/74020/74020_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 7980 | BAXTER S.L. | 2011-05-09 | 1 | 1 | 1 | 2021-02-03 | 2021-02-03 | 1 | 2021-05-19 | View Edit Delete | ||||||||||||
| 677327 | 73767 | CELSIOR SOLUCION PARA LA CONSERVACION DE ORGANOS | CELSIOR SOLUCION PARA LA CONSERVACION DE ORGANOS, 4 bolsas de 1.000 ml | N/A (más de 4 PA) | 3 | 4 | 65 | 4 bolsas de 1.000 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/73767/73767_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/73767/73767_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 13503 | INSTITUT GEORGES LOPEZ | 2011-03-29 | 1 | 1 | 1 | 2011-03-29 | 2011-03-29 | 1 | 2012-03-30 | View Edit Delete | ||||||||||||
| 679597 | 61076 | MOVALIS 15 mg COMPRIMIDOS | MOVALIS 15 mg COMPRIMIDOS , 20 comprimidos | 15 mg | 5 | 20 | 10 | 20 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/61076/61076_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/61076/61076_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 5126 | BOEHRINGER INGELHEIM ESPANA S.A. | 1996-10-01 | 1 | 1 | 1 | 1996-10-01 | 1996-10-01 | 1 | 2011-10-25 | View Edit Delete | ||||||||||||
| 679605 | 61075 | MOVALIS 7,5 mg COMPRIMIDOS | MOVALIS 7,5 mg COMPRIMIDOS, 20 comprimidos | 7,5 mg | 5 | 20 | 10 | 20 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/61075/61075_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/61075/61075_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 5126 | BOEHRINGER INGELHEIM ESPANA S.A. | 1996-10-01 | 1 | 1 | 1 | 1996-10-01 | 1996-10-01 | 1 | 2011-10-25 | View Edit Delete | ||||||||||||
| 679565 | 73875 | LACIDIPINO TEVA 4 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | LACIDIPINO TEVA 4 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG , 28 comprimidos | 4 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/73875/73875_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/73875/73875_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 34492 | TEVA GENERICOS ESPAÑOLA S.L. | 2011-04-13 | 1 | 1 | 1 | 2011-04-13 | 2011-04-13 | 1 | 2012-01-25 | View Edit Delete | ||||||||||||
| 676999 | 61241 | VALTREX 1.000 mg COMPRIMIDOS RECUBIERTOS CON PELÍCULA | VALTREX 1.000 mg COMPRIMIDOS RECUBIERTOS CON PELÍCULA , 21 comprimidos | 1.000 mg | 5 | 21 | 10 | 21 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/61241/61241_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/61241/61241_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3732 | GLAXOSMITHKLINE S.A. | 2002-11-13 | 1 | 1 | 1 | 2002-11-13 | 2002-11-13 | 0 | 2012-01-02 | View Edit Delete | ||||||||||||
| 679811 | 61240 | VALTREX 500 mg COMPRIMIDOS RECUBIERTOS CON PELICULA | VALTREX 500 mg COMPRIMIDOS RECUBIERTOS CON PELICULA , 10 comprimidos | 500 mg | 5 | 10 | 10 | 10 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/61240/61240_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/61240/61240_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3732 | GLAXOSMITHKLINE S.A. | 1996-12-01 | 1 | 1 | 1 | 1996-12-01 | 2001-02-01 | 0 | 2012-01-02 | View Edit Delete | ||||||||||||
| 679837 | 61240 | VALTREX 500 mg COMPRIMIDOS RECUBIERTOS CON PELICULA | VALTREX 500 mg COMPRIMIDOS RECUBIERTOS CON PELICULA , 42 comprimidos | 500 mg | 5 | 42 | 10 | 42 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/61240/61240_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/61240/61240_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3732 | GLAXOSMITHKLINE S.A. | 1996-12-01 | 1 | 1 | 1 | 1996-12-01 | 2001-02-01 | 0 | 2012-01-02 | View Edit Delete | ||||||||||||
| 675601 | 72917 | VALSARTAN NORMON 320 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | VALSARTAN NORMON 320 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG , 28 comprimidos | 320 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/72917/72917_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/72917/72917_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6638 | LABORATORIOS NORMON S.A. | 2011-03-29 | 1 | 1 | 1 | 2018-12-12 | 2018-12-12 | 1 | 2012-02-21 | View Edit Delete |
Page 270 of 1036, showing 20 records out of 20702 total, starting on record 5381, ending on 5400